RESUMO
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal.
RESUMO
Global Navigation Satellite System (GNSS) signals generate slant tropospheric delays when they pass through the atmosphere, which is recognized as the main source of error in many spatial geodetic applications. The zenith tropospheric delay (ZTD) derived from radio occultation data is of great significance to atmospheric research and meteorology and needs to be assessed in the use of precision positioning. Based on the atmPrf, sonPrf, and echPrf data from the Constellation Observing System for Meteorology, Ionosphere, and Climate (COSMIC) Data Analysis and Archiving Center (CDAAC) from 1 January to 31 December 2008 and 2012, we obtained the ZTDs of the radio occultation data (occZTD) and the corresponding radiosonde (sonZTD) and ECWMF data (echZTD). The ZTDs derived from ground-based global positioning system (GPS) observations from the International GNSS Service (IGS) were corrected to the lowest tangent point height of the matched radio occultation profile by the barometric height formula (gnsZTD). The statistical results show that the absolute values of the bias between occZTD and echZTD, sonZTD, or gnsZTD are less than 5 mm, and the standard deviations are approximately 20 mm or less, indicating that occZTD had significant accuracy in the GNSS positioning model even when the local spherical symmetry assumption error was introduced when the Abel inversion algorithm was used to obtain the refractive index profile of atmPrf. The effects of the horizontal/vertical matching resolution and the variation in the station height/latitude on the biases of occZTD and gnsZTD were analyzed. The results can be used to quantify the performance of radio occultation data for tropospheric delay error correction in dynamic high-precision positioning.
RESUMO
Our conceived approach based on the directed assembly of functional metal-organic squares (MOSs), 4-membered ring (4MR) building units, permitted the construction of two novel zeolite-like supramolecular assemblies (ZSAs), namely [Co4 (ImDC)4 (En)4 ]â 9 H2 Oâ 1.5 DMF (ZSA-10) and [Co4 (ImDC)4 (En)4 ]â 7 H2 O (ZSA-11) (H3 ImDC=4,5-imidazoledicarboxylic acid, En=ethylenediamine, DMF=N,N-dimethylformamide). The elected MOSs encompass both trans- and cis-coordinated nodes, offering complementary peripheral functional groups for their directed assembly into zeolite-like topologies via supramolecular hydrogen bonding interactions. Distinctly, ZSA-10 possesses the underling MER zeolite topology and is the only pure MER framework material (without any supporting templates) exhibiting permanent porosity up to now. ZSA-11 has the underlying ABW topology together with one type of narrow channel.
RESUMO
Two stable Zn-cluster-based MOFs, [Zn9(btz)12(atdbc)3(DMF)]·3DMF·12H2O (compound 1, Hbtz = 1 H-benzotriazole, H2atdbc = 4,4'-(4-amino-1,2,4-triazol-3,5-diyl)dibenzoic acid, DMF = N, N-dimethylformamide) and [Zn4(btz)6(bcpt)]·3DMF (compound 2, H2bcpt = 3,5-bis(4'-carboxy-phenyl)-1,2,4-triazole), have been successfully constructed by adopting the mixed ligands approach. Both the compounds exhibit high chemical stability under aqueous solution and common organic solvents. Especially, compounds 1 and 2 can be stable in pH = 2 and pH = 12 solutions. Meanwhile, compound 1 exhibits good ability to selectively separate CO2 from CH4. CO2 over CH4 selectivity is 5.2 (0.5/0.5) and 5.7 (0.05/0.95) at 298 K under 1 bar, respectively, which may be used for the separation of gases in industrial applications. Moreover, compound 1 displays breathing behavior for small-molecule gases (N2, CO2, C2H6, and C3H8), and compound 2 only exhibits the same phenomenon for CO2 adsorption because of its ultramicroporous channels.
RESUMO
LRRC3B has emerged as a tumor suppressor in several human cancers. However, its expression pattern and biological roles in human non-small-cell lung cancer (NSCLC) have not been explored. In the present study, we investigated clinical significance of LRRC3B in 101 NSCLC specimens. We found that LRRC3B expression was downregulated in NSCLC tissues compared with normal bronchial epithelium and that its downregulation significantly correlated with tumor-node-metastasis (TNM) stage (p < 0.0001), nodal metastasis (p < 0.0001), and poor patient prognosis (p = 0.0016, log-rank test). We also checked LRRC3B levels in several lung cancer cell lines and found that its expression was downregulated in four of nine lung cancer cell lines compared with normal human bronchial epithelial (NHBE) cell line. We further explored the biological role of LRRC3B. LRRC3B plasmid transfection in H460 and A549 cell lines inhibited proliferation, colony formation ability, and invading ability. Furthermore, we identified that LRRC3B could inhibit cell cycle progression with downregulation of cyclin D1 and decreased MMP9 expression. In addition, LRRC3B depletion in HBE cells promoted proliferation and invasion. In conclusion, our data suggested that LRRC3B may serve as an important tumor suppressor in NSCLC.
Assuntos
Carcinoma Pulmonar de Células não Pequenas/metabolismo , Regulação Neoplásica da Expressão Gênica , Neoplasias Pulmonares/metabolismo , Proteínas de Neoplasias/metabolismo , Células A549 , Idoso , Linhagem Celular Tumoral , Proliferação de Células , Ciclina D1/metabolismo , Regulação para Baixo , Feminino , Humanos , Masculino , Metaloproteinase 9 da Matriz/metabolismo , Pessoa de Meia-Idade , Invasividade Neoplásica , Metástase Neoplásica , RNA Interferente Pequeno/metabolismo , Reação em Cadeia da Polimerase em Tempo RealRESUMO
BACKGROUND: MicroRNA-663a expression is downregulated in several tumors. However, its functions and mechanisms in human non-small cell lung (NSCLC) cancer remain obscure. The present study aimed to identify the expression pattern, biological roles and potential mechanisms by which miR-663a dysregulation is associated with NSCLC. METHODS: We examined expression level of miR-663a in 62 cases of NSCLC tissues and 5 NSCLC cell lines by reverse transcription PCR. In vitro, gain-of-function and loss-of-function experiments were performed to examine the impact of miR-663a on proliferation, cell cycle progression and invasion of NSCLC cells. Using fluorescence reporter assays, we also explored the potential targets and possible mechanisms of miR-663a in NSCLC cells. RESULTS: Downregulation of miR-663a was observed in 42 of 62 of lung cancer tissues compared with paired normal tissues (mean cancer/normal value = 0.745) and its downregulation correlated with nodal metastasis. Transfection of miR-663a mimic suppressed cell proliferation, cell cycle progression and invasion, with downregulation of cyclin D1, cyclin E and MMP9 in both H460 and H1299 cell lines. Transfection of miR-663a inhibitor in both H460 and H1299 cell lines exhibited the opposite effects. In addition, we confirmed that miR-663a could inhibit AP-1 activity and AP-1 component JunD was a direct target of miR-663a in lung cancer cells. Transfection of miR-663a mimic downregulated JunD expression. In addition, JunD siRNA treatment abrogated miR-663a inhibitor-induced expression of cyclin D1, cyclin E and MMP9. Above all, both miRNA mimic and inhibitor in two different NSCLC cell lines demonstrated that miR-663a inhibits proliferation and invasion by targeting AP-1 transcription factor JunD. CONCLUSIONS: This study indicates that miR-663a downregulation might be associated with NSCLC progression. MiR-663a suppresses proliferation and invasion by targeting AP-1 component JunD in NSCLC cells.
Assuntos
Carcinoma Pulmonar de Células não Pequenas/genética , Neoplasias Pulmonares/genética , MicroRNAs/fisiologia , Proteínas Proto-Oncogênicas c-jun/genética , Carcinoma Pulmonar de Células não Pequenas/metabolismo , Linhagem Celular Tumoral , Proliferação de Células , Regulação para Baixo , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Neoplasias Pulmonares/metabolismo , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica , Proteínas Proto-Oncogênicas c-jun/metabolismo , Interferência de RNARESUMO
Our previous study reported that waltonitone treatment inhibited proliferation and induced apoptosis of lung cancer cells. However, the mechanism of waltonitone-induced toxicity remains unclear. In the present study, we treated H460 and H3255 lung cancer cells using different concentration of waltonitone (0, 10, 20, 30 µmol/L). We observed that waltonitone inhibited cell viability and induced apoptosis in a concentration dependent manner, with upregulation of caspase-3 cleavage. We also observed upregulation of miR-663, a potential tumor suppressor, after waltonitone treatment. Suppression of miR-663 function using miR-663 inhibitor partly alleviated cell toxicity induced by waltonitone. In addition, both waltonitone treatment and transfection of miR-663 mimic upregulated Bcl-2 mRNA and protein expression. Bcl-2 transfection alleviated waltonitone-induced toxicity. Furthermore, transfection of miR-663 inhibitor upregulated Bcl-2 levels in both cell lines. In summary, the present study demonstrated that waltonitone induced apoptosis of lung cancer cells through, at least partly, miR-663-induced Bcl-2 downregulation.
Assuntos
Carcinoma Pulmonar de Células não Pequenas/genética , MicroRNAs/biossíntese , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Triterpenos/administração & dosagem , Apoptose/efeitos dos fármacos , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Carcinoma Pulmonar de Células não Pequenas/patologia , Caspase 3/metabolismo , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , MicroRNAs/genética , Proteínas Proto-Oncogênicas c-bcl-2/genéticaRESUMO
ARID1A (AT-rich interactive domain 1A) is a key member of the SWI/SNF chromatin-modeling complex, and the gene has emerged as a tumor suppressor in various human cancers. In the present study, we investigated the expression and clinical significance of ARID1A in non-small cell lung cancer (NSCLC). We found that ARID1A expression was decreased in NSCLC tissues compared with normal bronchial epithelium and was significantly correlated with nodal metastasis, tumor, node, metastasis (TNM) stage, and poor differentiation. ARID1A expression was lower in lung cancer cell lines than normal bronchial epithelial HBE cell line. We also explored the involvement of ARID1A in biological behavior of lung cancer cell lines. ARID1A depletion by small interfering RNA (siRNA) in H460 and H1299 cell lines promoted proliferation, colony formation ability, and inhibited paclitaxel-induced apoptosis. Furthermore, we identified that ARID1A regulated several cell cycle and apoptosis-related targets such as cyclin D1 and Bcl-2. In addition, the activity of Akt phosphorylation was also enhanced after ARID1A depletion. In conclusion, our data suggested that ARID1A may serve as an important tumor suppressor in NSCLC.
Assuntos
Apoptose , Carcinoma Pulmonar de Células não Pequenas/patologia , Proliferação de Células , Neoplasias Pulmonares/patologia , Proteínas Nucleares/fisiologia , Fatores de Transcrição/fisiologia , Proteínas Supressoras de Tumor/fisiologia , Adulto , Idoso , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Carcinoma Pulmonar de Células não Pequenas/mortalidade , Ciclina D1/metabolismo , Proteínas de Ligação a DNA , Regulação para Baixo , Feminino , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/mortalidade , Masculino , Pessoa de Meia-Idade , Proteínas Nucleares/análise , Fosforilação , Proteínas Proto-Oncogênicas c-akt/metabolismo , Fatores de Transcrição/análiseRESUMO
Bone defect has always been a difficult problem in clinical work. According to the current research results, tissue engineered scaffolds with a single function, structure, and composition are not sufficient to repair complex bone defects. In this work, a three-dimensional (3D) chitosan degradable composite scaffold loaded with zinc oxide (ZnO) was constructed, and the effect of ZnO content on scaffold performance and osteogenesis was explored. The 3D composite scaffold was prepared by freeze-drying technology. The microstructure, porosity, degradation performance, release performance, swelling performance, cytotoxicity, cell adhesion and osteogenic ability of ZnO nanoparticles and chitosan (ZnONPs/CS) composite scaffolds were measured. The results show that an appropriate amount of ZnO may be helpful to regulate the stability and degradation characteristics of the scaffold to a certain extent. Moreover, the composite scaffold could release ZnO into the simulated body fluid environment. The appropriate amount of ZnO helps to promote the proliferation, adhesion, and osteogenic differentiation of MC3T3-E1 cells. At a ZnO content of 3â¯wt%, both in vitro and vivo results showed relatively optimal biocompatibility and bioactivity of the scaffolds. This work could at least provide some positive insights for the selection of ZnO dosage, construction of chitosan-based 3D scaffolds, tissue engineering applications, and clinical treatment.
RESUMO
Integrating the advantages of homogeneous and heterogeneous catalysis has proved to be an optimal strategy for developing catalytic systems with high efficiency, selectivity, and recoverability. Supramolecular metal-organic cages (MOCs), assembled by the coordination of metal ions with organic linkers into discrete molecules, have performed solvent processability due to their tunable packing modes, endowing them with the potential to act as homogeneous or heterogeneous catalysts in different solvent systems. Here, the design and synthesis of a series of stable {Cu3} cluster-based tetrahedral MOCs with varied packing structures are reported. These MOCs, as homogeneous catalysts, not only show high catalytic activity and selectivity regardless of substrate size during the CO2 cycloaddition reaction, but also can be easily recovered from the reaction media through separating products and co-catalysts by one-step work-up. This is because that these MOCs have varied solubilities in different solvents due to the tunable packing of MOCs in the solid state. Moreover, the entire catalytic reaction system is very clean, and the purity of cyclic carbonates is as high as 97% without further purification. This work provides a unique strategy for developing novel supramolecular catalysts that can be used for homogeneous catalysis and recycled in a heterogeneous manner.
RESUMO
LncRNA PSMA3-AS1 functions as an oncogene in several cancers, including ovarian cancer, lung cancer, and colorectal cancer. However, its role in gastric cancer (GC) progression remains unclear. In this study, the levels of PSMA3-AS1, miR-329-3p, and aldolase A (ALDOA) in 20 paired human GC tissues and adjacent nontumorous tissues were measured by real-time PCR. GC cells were transfected with recombinant plasmid carrying full-length PSMA3-AS1 or shRNA targeting PSMA3-AS1. The stable transfectants were selected by G418. Then, the effects of PSMA3-AS1 knockdown or overexpression on GC progression in vitro and in vivo were evaluated. The results showed that PSMA3-AS1 was highly expressed in human GC tissues. Stable knockdown of PSMA3-AS1 significantly restrained proliferation/migration/invasion, enhanced cell apoptosis, and induced oxidative stress in vitro. Tumor growth and matrix metalloproteinase expression in tumor tissues were markedly inhibited, while oxidative stress was enhanced in nude mice after stable PSMA3-AS1 knockdown. Additionally, PSMA3-AS1 negatively regulated miR-329-3p while positively regulated ALDOA expression. MiR-329-3p directly targeted ALDOA-3'UTR. Interestingly, miR-329-3p knockdown or ALDOA overexpression partially attenuated the tumor-suppressive effects of PSMA3-AS1 knockdown. Conversely, PSMA3-AS1 overexpression exhibited the opposite effects. PSMA3-AS1 promoted GC progression by regulating the miR-329-3p/ALDOA axis. PSMA3-AS1 might serve as a promising and effective target for GC treatment.
Assuntos
MicroRNAs , RNA Longo não Codificante , Neoplasias Gástricas , Animais , Camundongos , Humanos , Neoplasias Gástricas/genética , MicroRNAs/genética , MicroRNAs/metabolismo , RNA Longo não Codificante/genética , RNA Longo não Codificante/metabolismo , Frutose-Bifosfato Aldolase/genética , Frutose-Bifosfato Aldolase/metabolismo , Camundongos Nus , Proliferação de Células/genética , Linhagem Celular Tumoral , Regulação Neoplásica da Expressão Gênica , Movimento Celular/genética , Complexo de Endopeptidases do Proteassoma/genética , Complexo de Endopeptidases do Proteassoma/metabolismoRESUMO
Purpose: Curcumin and icariin have multiple pharmacological effects and are widely used in various fields, but their short half-life, poor bioavailability and low water solubility greatly limit their application in clinical medicine. Poly(lactide-co-glycolide) (PLGA) loaded microspheres not only solve these problems, but also have no toxicity in degradation. Methods: To verify whether PLGA drugloaded microspheres have good biocompatibility, the present experiments used the emulsification-solvent evaporation method to prepare PLGA drug-loaded microspheres and successfully performed the loading of curcumin and icariin. Results: The scanning electron microscopy showed that the particle sizes of the PLGA microspheres were 2-15 µm, icariin/PLGA microspheres were 3-22 µm and curcumin/PLGA microspheres were 5-30 µm. Moreover, the surface of the microspheres was smooth and spherical. Furthermore, the drug loading and encapsulation rate were good. In vitro experiments revealed that the prepared PLGA microspheres were safe and nontoxic, and that they could release drugs stably and slowly. Moreover, their proliferation ability was unaffected after inoculation into bone marrow mesenchymal stem cells (BMSCs), and Alcian blue Staining was performed at last, demonstrating their biocompatibility and important applications in tissue engineering.
Assuntos
Materiais Biocompatíveis , Células-Tronco Mesenquimais , Microesferas , Materiais Biocompatíveis/farmacologia , Animais , Células-Tronco Mesenquimais/efeitos dos fármacos , Células-Tronco Mesenquimais/citologia , Teste de Materiais , Copolímero de Ácido Poliláctico e Ácido Poliglicólico/química , Proliferação de Células/efeitos dos fármacos , Curcumina/farmacologia , Curcumina/química , Curcumina/farmacocinética , Tamanho da Partícula , Poliglactina 910/químicaRESUMO
Cartilage tissue regeneration is tremendously tough, it has become a major clinical challenge for the orthopedic medical community. Because of their bionic structure, high water content, biocompatibility, and biodegradability, hydrogels derived from natural polysaccharide are excellent candidates for cartilage tissue engineering. However, these materials often face problems such as poor mechanical strength and excessive swelling, which limit their clinical application. This study used a chemical-physical multi-step cross-linking strategy to create double-network (DN) microcrystalline cellulose (MCC) hydrogels. The hydrogels' intrinsic biomimetic macroporous shape and high water content made them ideal for chondrocyte adhesion and proliferation. The performance requirements for cartilage tissue engineering scaffolds are met by DN hydrogels, which have a sufficiently high compressive strength (4.53 MPa), superior compression recovery, and fatigue resistance, compared to single-network (SN) hydrogels. According to in vitro findings, DN hydrogels could boost cell adhesion and proliferation due to their safe and non-toxic nature. Hydrogels were demonstrated to be stable over the long-term performance, to degrade slowly, and to have strong histocompatibility by in vivo implantation. To construct cartilage tissue engineering scaffold and conduct three-dimensional cell culture, DN hydrogels have significant potential.
Assuntos
Hidrogéis , Engenharia Tecidual , Hidrogéis/farmacologia , Hidrogéis/química , Alicerces Teciduais/química , Cartilagem , ÁguaRESUMO
Effective separation of ethyne from ethyne/ethylene (C2 H2 /C2 H4 ) mixtures is a challenging and crucial industrial process. Herein, an ultra-microporous metal-organic framework (MOF) platform, Cd(dicarboxylate)2 (ditriazole), with triangular channels is proposed for high-efficiency separation of C2 H2 from C2 H4 . The targeted structures are constructed via a mixed-ligand strategy by selecting different-sized ligands, allowing for tunable pore sizes and volumes. The pore properties can be further optimized by additional modification via pore environment tailoring. This concept leads to the successful synthesis of three ultra-microporous Cd-MOFs (JLU-MOF87-89). As intended, C2 H2 uptake and C2 H2 /C2 H4 selectivity gradually increase with progressively optimizing the pore structure by adjusting ligand length and substituents. JLU-MOF89, functionalized with methyl groups, features the most optimal pore chemistry and shows selective recognition of C2 H2 over C2 H4 , owing to the framework-C2 H2 host-guest interactions. Furthermore, JLU-MOFs are fabricated into mixed-matrix membranes for C2 H2 /C2 H4 separation. C2 H2 permeability and C2 H2 /C2 H4 permselectivity are substantially enhanced by ≥400% and ≥200%, respectively, after hybridization of JLU-MOF88 and JLU-MOF89 with a polyimide polymer (6FDA-ODA). These membranes can work efficiently and are stable under different conditions, demonstrating their potential in actual ethyne separation.
RESUMO
Background: Common genetic risk variants for prostate cancer (PCa) have been identified at approximately 170 loci using genome-wide association studies (GWAS), most of which were identified in European populations. Recently, GWAS were applied to a large Japanese cohort and identified 12 novel susceptibility loci associated with PCa risk. In this study, we aim to investigate PCa susceptibility loci in the Chinese population. The study data will be used to promote PCa risk control in China. Methods: A total of 235 PCa patients and 252 control subjects (all unrelated) were enrolled in this case-control PCa study. Nine single nucleotide polymorphisms (SNPs) were genotyped in GATA2 (rs73862213, rs2335052, and rs10934857), ZMIZ1 (rs704017, rs77911174, and rs3740259), and SUN2 (rs78397383, rs5750680, and rs138705) genes. The associations between the candidate SNPs and PCa were analyzed using multiple-factor logistic regression and haplotype analysis. Results: The allele frequency distributions of rs73862213 and rs2335052 in the GATA2 gene and rs704017 and rs77911174 in the ZMIZ1 gene were found to be significantly different between PCa cases and controls. Haplotype analysis revealed that the G-C-A haplotype of the GATA2 gene (order of SNPs: rs73862213-rs2335052-rs10934857) and the G-G-G haplotype of the ZMIZ1 gene (order of SNPs: rs704017-rs77911174-rs3740259) were associated with increased PCa risk. None of the SUN2 haplotypes were associated with PCa. Conclusions: Our study data indicates that the minor alleles of rs73862213 and rs2335052 in the GATA2 gene and rs704017 and rs77911174 in the ZMIZ1 gene were associated with increased PCa risk. These findings greatly extended our knowledge of the etiology of PCa.
RESUMO
Mimicking natural photosynthesis to convert CO2 with H2O into value-added fuels achieving overall reaction is a promising way to reduce the atmospheric CO2 level. Casting the catalyst of two or more catalytic sites with rapid electron transfer and interaction may be an effective strategy for coupling photocatalytic CO2 reduction and H2O oxidation. Herein, based on the MOF ⪠COF collaboration, we have carefully designed and synthesized a crystalline hetero-metallic cluster catalyst denoted MCOF-Ti6Cu3 with spatial separation and functional cooperation between oxidative and reductive clusters. It utilizes dynamic covalent bonds between clusters to promote photo-induced charge separation and transfer efficiency, to drive both the photocatalytic oxidative and reductive reactions. MCOF-Ti6Cu3 exhibits fine activity in the conversion of CO2 with water into HCOOH (169.8 µmol g-1h-1). Remarkably, experiments and theoretical calculations reveal that photo-excited electrons are transferred from Ti to Cu, indicating that the Cu cluster is the catalytic reduction center.
RESUMO
BACKGROUND: Rheumatoid arthritis (RA) is a chronic autoimmune disease of articular joint damage and elevated synovial hyperplasia. Abnormal proliferation, invasion inflammatory response of rheumatoid fibroblast-like synoviocytes (RA-FLS) play a critical role in RA progression. Mesenchymal stem cell (MSC)-derived exosomal circular RNAs are promising therapeutic manner for disease treatment. This work aimed to decipher the role of exosomal circFBXW7 in RA. METHODS: The expression of circFBXW7, miR-216a-3p, and HDAC4 were detected in clinical RA samples. The RA rat model was established. Isolation and identification of exosomes from MSCs was conducted. The effects of exosomal circFBXW7 on RA was evaluated by qPCR, CCK-8, transwell assays, flow cytometry, Western blotting, ELISA, and immunohistochemical assay. Interaction between miR-216a-3p and circFBXW7 or HDAC4 was determined by luciferase reporter gene assay and RNA pulldown. RESULTS: Exosomal circFBXW7 treatment suppressed proliferation, migration and inflammatory response of RA-FLSs and damage of RA model. CircFBXW7 could directly sponge miR-216a-3p to upregulate the expression of HDAC4. Inhibition of HDAC4 or upregulation of miR-216a-3p abolished the therapeutic function of exosomal circFBXW7. Our data demonstrated that circFBXW7 and HDAC4 were decreased, and miR-216a-3p was elevated in clinical RA sample compared with healthy samples. CONCLUSION: We concluded that MSC-derived exosomal circFBXW7 suppressed proliferation, migration and inflammatory response of RA-FLSs and damage of RA rats via sponging miR-216a-3p and release the activation of HDAC4. These findings may provide a novel therapeutic target for RA.
RESUMO
On the basis of different V-shaped ligands, three zirconium-organic frameworks (JLU-Liu45, Zr-SDBA, and Zr-OBBA) have been successfully constructed. By regulating spatial configuration and functional groups of organic ligands, these as-synthesized Zr-MOFs (MOF = metal-organic framework) display distinct structures and different light hydrocarbon adsorption/separation capabilities. JLU-Liu45, with a double-walled interpenetrated 3D primitive cubic (pcu) framework, exhibits good gas-adsorption capacity but not prominent selective separation ability. Through regulating sizes and torsion angles of the organic ligands, Zr-SDBA possesses a 2D square lattice (sql) network, while Zr-OBBA displays a non-interpenetrated 3D pcu framework. Furthermore, by regulating functional groups on the ligands, Zr-SDBA shows prominent C2H2 uptake (101.2 cm3·g-1) and the best C2H2/CH4 selectivity (230.5, 1:1) among the three Zr-MOFs, and Zr-OBBA shows a significant C3H8/CH4 selectivity (105.6, 1:1). This work demonstrates the feasibility of structural regulation for MOF materials in the light hydrocarbon adsorption/separation field.
RESUMO
PURPOSE: Multifocal and multicentric glioblastomas (mGBMs) are associated with a poorer prognosis compared to unifocal glioblastoma (uGBM). The presence of CD8+ tumor-infiltrating lymphocytes (TILs) is predictive of clinical outcomes in human malignancies. Here, we examined the CD8+ lymphocytic infiltration in mGBMs. METHODS: The clinical data of 57 consecutive IDH wildtype primary mGBM patients with histopathological diagnoses were retrospectively reviewed. CD8+ TILs were quantitatively evaluated by immunohistochemical staining. The survival function of CD8+ TILs was assessed by Kaplan-Meier analysis and Cox proportional hazard models. RESULTS: No significant difference in the concentration of CD8+ TILs was observed among foci from the same patient (P>0.150). The presence of CD8+ TILs was similar between multifocal and multicentric GBMs (P=0.885). The concentration of CD8+ TILs was significantly lower in mGBMs than in uGBMs (P=0.002). In mGBM patients, the CD8+ TIL level was associated with preoperative KPS (P=0.018). The median overall survival (OS) of the 57 mGBMs was 9 months. A low CD8+ TIL level (multivariate HR 4.404, 95% CI 1.954-9.926, P=0.0004) was an independent predictor of poor OS, while postoperative temozolomide chemotherapy (multivariate HR 6.076, 95% CI 2.330-15.842, P=0.0002) was independently associated with prolonged OS in mGBMs. CONCLUSIONS: Decreased CD8+ TIL levels potentially correlate with unfavorable clinical outcome in mGBMs, suggesting an influence of the local immuno-microenvironment on the progression of mGBMs.
RESUMO
Adopting the mixed ligands approach, two water-stable Zn5 cluster-based MOFs, [Zn10(TZ)12(TADIPA)2(DMF)4]·DMF·6H2O (JLU-MOF66) and [Zn10(TZ)12(TPTA)2(DMA)2]·2DMA·4H2O (JLU-MOF67), have been constructed (H4TADIPA = 5,5'-(1H-1,2,4-triazole-3,5-diyl)diisophthalic acid, H4TPTA = [1,1':3',1â³-terphenyl]-3,3â³,5,5â³-tetracarboxylic acid, and HTZ = 1H-[1,2,3]triazole). Both compounds with [Zn5(TZ)6] clusters exhibit extraordinary stability (pH = 2-11) and selectivity of C3H8/CH4 (308 for JLU-MOF66, and 287 for JLU-MOF67). Compared to JLU-MOF67, JLU-MOF66 with functional groups exhibits higher CO2 and C2H2 uptake capacity and excellent selective separation for C2H2/CH4 (86, 1:1). Such high separation and chemical stability render them as promising materials for industrial applications.